# Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/metabolic-testing-rates-in-3-state-medicaid-programs-after-fda-warnings-and-ada/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elaine H. Morrato,Benjamin G. Druss,Daniel M. Hartung,Robert J. Valuck,Richard R. Allen,Elizabeth J. Campagna,John W. Newcomer |
| Citations | 201 |
| DOI | 10.1001/archgenpsychiatry.2009.179 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2156587838 |
| PMID | 20048219 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Daniel M. Hartung](https://scholariq.org/researchers/daniel-m-hartung/)

## Paper primary topic

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Paper topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.